McLaren Flint is a nonprofit, 378 bed tertiary teaching hospital located in Flint, Michigan. McLaren is affiliated with the Michigan State University College of Human Medicine's medical residency programs, including family medicine, internal medicine, general surgery, orthopedic surgery and radiology.

There are 378 beds in McLaren Flint.

During the past decade, McLaren Flint conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 12 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 5 clinical trials were completed. i.e. 71.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "McLaren Flint" #1 sponsor was "Radiation Therapy Oncology Group" with 3 trials, followed by "Abbott Medical Devices" with 2 trials sponsored, "Alexion" with 2 trials sponsored, "Celgene" with 2 trials sponsored and "McLaren Regional Medical Center" with 2 trials sponsored. Other sponsors include 13 different institutions and companies that sponsored additional 22 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "McLaren Flint" #1 collaborator was "National Institute of Neurological Disorders and Stroke (NINDS)" with 5 trials as a collaborator, "Medical University of South Carolina" with 3 trials as a collaborator, "NRG Oncology" with 3 trials as a collaborator, "National Cancer Institute (NCI)" with 3 trials as a collaborator and "University of Cincinnati" with 3 trials as a collaborator. Other collaborators include 11 different institutions and companies that were collaborators in the rest 21 trials.

According to Clinical.Site data, the most researched conditions in "McLaren Flint" are "Stroke" (5 trials), "Carotid Artery Disease" (3 trials), "Coronary Artery Disease" (3 trials), "Prostate Cancer" (3 trials) and "Ischemic Stroke" (2 trials). Many other conditions were trialed in "McLaren Flint" in a lesser frequency.

Most popular intervention types in "McLaren Flint" are "Drug" (17 trials), "Device" (7 trials), "Other" (5 trials), "Biological" (3 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Apixaban" (2 trials), "Aspirin" (2 trials), "ASA 100 mg" (1 trials) and "Anti-androgen" (1 trials). Other intervention names were less common.

The vast majority of trials in "McLaren Flint" are 24 trials for "All" genders, 3 trials for "Male" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "McLaren Flint". undefined are not yet recruiting, 5 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 17 completed trials in McLaren Flint, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in McLaren Flint, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 17 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 7 trials that are defined as “Not Applicable".